Vaxar 25 Capsule

About Vaxar 25 Capsule

Vaxar 25 is a capsule containing 25 mg of pregabalin, made by Nuvista Pharma Ltd. It is used in nerve pain conditions and as an add-on treatment for certain seizures, and it belongs to a group of medicines called adjunct anti-epileptic drugs.

There are 105 brands of Pregabalin listed in Bangladesh. The lowest listed price is GAPA-P 150 mg Capsule at ৳ 1 per unit.

What is Vaxar 25 Capsule?

Vaxar 25 is a 25 mg capsule of pregabalin, an adjunct anti-epileptic medicine from Nuvista Pharma Ltd. It is prescribed for nerve pain linked to diabetes, pain after shingles, fibromyalgia and nerve pain from spinal cord injury, and it is also used alongside other medicines for partial-onset seizures. Pregabalin works in the central nervous system, and its exact way of working is not fully understood. It can cause dizziness and drowsiness, so care is needed with activities like driving until you know how it affects you. Your doctor will decide whether it suits you and will set the dose and course.

Uses of Vaxar 25

Vaxar 25 is used for nerve pain from diabetic peripheral neuropathy, pain after shingles (postherpetic neuralgia), fibromyalgia and nerve pain from spinal cord injury. It is also used as add-on therapy for partial-onset seizures. It is not a painkiller for everyday aches, and it should only be taken when a doctor has prescribed it for one of these conditions.

How to use Vaxar 25

Take Vaxar 25 exactly as your doctor tells you. The doctor decides the dose, how often to take it and how long the course lasts, and may adjust it over time. Swallow the capsule as directed. Do not change the dose or stop suddenly on your own, because stopping needs to be managed by your doctor. Ask your pharmacist if you are unsure how to take it.

Side effects of Vaxar 25

Common side effects include dizziness, sleepiness, dry mouth, swelling, blurred vision, weight gain and trouble concentrating. Children taking pregabalin for partial-onset seizures may show increased weight and appetite. Tell your doctor if side effects bother you or do not settle. Get urgent help for swelling of the throat, head or neck, hives, trouble breathing or wheezing, and tell your doctor about any changes in mood or thoughts.

Safety and precautions

Do not take Vaxar 25 if you have had an allergic reaction to pregabalin or any of its ingredients. It can cause swelling of the throat, head and neck, and allergic reactions; stop it and get help at once if these occur. It may raise the risk of suicidal thoughts or behaviour, and breathing problems can occur when used with other medicines that slow the nervous system or in people with breathing problems. There are no adequate studies in pregnancy, so pregnant women should be told of the possible risk to the fetus. Small amounts pass into breast milk, and breastfeeding is not recommended during treatment. Tell your doctor about pregnancy, breastfeeding, kidney problems or other medicines before starting.

Frequently asked questions

What is Vaxar 25 used for, and what kind of medicine is it?

Vaxar 25 is a pregabalin capsule used for certain nerve pain conditions, fibromyalgia and as add-on treatment for partial-onset seizures. It is an adjunct anti-epileptic medicine that acts on the central nervous system. Your doctor will confirm whether it is suitable for your condition.

How should Vaxar 25 be taken?

Take it as your doctor directs. The doctor decides the dose, how often it is taken and how long the course lasts, and may change it over time. Do not alter the dose or stop suddenly without advice. Ask your pharmacist if anything is unclear.

Is Vaxar 25 safe in pregnancy or breastfeeding?

There are no adequate studies of pregabalin in pregnant women, so pregnant women should be advised of the possible risk to the fetus. Small amounts pass into breast milk, and breastfeeding is not recommended during treatment. Tell your doctor if you are pregnant, planning pregnancy or breastfeeding.

Can Vaxar 25 cause drowsiness or affect driving?

Dizziness and sleepiness are common side effects, so avoid driving or using machines until you know how the medicine affects you. It can also cause blurred vision and trouble concentrating. Tell your doctor if these effects bother you or do not settle.

Indications

Pregabalin is indicated for:
  • Neuropathic pain associated with diabetic peripheral neuropathy (DPN)
  • Postherpetic neuralgia (PHN)
  • Adjunctive therapy for the treatment of partial-onset seizures in patients 1 month of age and older
  • Fibromyalgia
  • Neuropathic pain associated with spinal cord injury
  • ... Read more
Pregabalin is indicated for:
  • Neuropathic pain associated with diabetic peripheral neuropathy (DPN)
  • Postherpetic neuralgia (PHN)
  • Adjunctive therapy for the treatment of partial-onset seizures in patients 1 month of age and older
  • Fibromyalgia
  • Neuropathic pain associated with spinal cord injury
Pregabalin CR tablet is indicated for:
  • Neuropathic pain associated with diabetic peripheral neuropathy (DPN)
  • Postherpetic neuralgia (PHN)

Pharmacology

Pregabalin is a structural derivative of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA). It does not bind directly to GABAA, GABAB or benzodiazepine receptors. Pregabalin binds with high affinity to the alpha2-delta site (an auxiliary subunit of voltage-gated calcium channels) in central nervous system tissues. Although the mechanism of action of Pregabalin has not been fully elucidated, results in animal studies suggest that binding to the alpha2-delta subunit may be involved in Pregabalin's anti-nociceptive and antiseizure effects.

Dosage & Administration

Neuropathic pain associated with diabetic peripheral neuropathy in adults (DPN): The maximum recommended dose of Pregabalin is 100 mg three times a day (300 mg/day) in patients with creatinine clearance of at least 60 ml/min. Dosing should begin at 50 mg three times a day (150 mg/day). The dose may be increased to 300 mg/day within 1 week based on efficacy and tolerability. Begin dosing of Pregabalin CR capsule at 165 mg once daily and increase to 330 mg once daily within 1 week based on individual patient response and tolerability. The maximum recommended dose of Pregabalin CR capsule is 330 mg once daily.

Postherpetic neuralgia in adults (PHN): The recommended dose of Pregabalin is 75 to 150 mg two times a day or 50 to 100 mg three times a day (150 to 300 mg/day) in patients with creatinine clearance of at least 60 ml/min. Dosing should begin at 75 mg two times a day or 50 mg three times a day (150 mg/day). The dose may be increased to 300 mg/day within 1 week based on efficacy and tolerability. Patients who do not experience sufficient pain relief following 2 to 4 weeks of treatment with 300 mg/day and who are able to tolerate Pregabalin, may be treated with up to 300 mg two times a day or 200 mg three times a day (600 mg/day).

Begin dosing of Pregabalin CR capsule at 165 mg once daily and increase to 330 mg once daily within 1 week based on individual patient response and tolerability. Patients who do not experience sufficient pain relief following 2 to 4 weeks of treatment with 330 mg once daily and who are able to tolerate Pregabalin CR capsule, may be treated with up to 660 mg once daily. In view of the dose-dependent adverse reactions and the higher rate of treatment discontinuation due to adverse reactions, dosing above 330 mg/day should be reserved only for those patients who have on-going pain and are tolerating 330 mg daily. The maximum recommended dose of Pregabalin CR capsule is 660 mg once daily.

Management of fibromyalgia in adults: The recommended dose of Pregabalin is 300 to 450 mg/day. Dosing should begin at 75 mg two times a day (150 mg/day). The dose may be increased to 150 mg two times a day (300 mg/day) within 1 week based on efficacy and tolerability. Patients who do not experience sufficient benefit with 300 mg/day may be further increased to 225 mg two times a day (450 mg/day).

Neuropathic pain associated with spinal cord injury in adults: The recommended dose range of Pregabalin is 150 to 600 mg/day. The recommended starting dose is 75 mg two times a day (150 mg/day). The dose may be increased to 150 mg two times a day (300 mg/day) within 1 week based on efficacy and tolerability. Patients who do not experience sufficient pain relief after 2 to 3 weeks of treatment with 150 mg two times a day and who tolerate Pregabalin may be treated with up to 300 mg two times a day.

Conversion from Pregabalin capsules to Pregabalin CR capsule tablet: When switching from Pregabalin capsules to Pregabalin CR capsule tablet on the day of the switch, instruct patients to take their morning dose of Pregabalin capsule as prescribed and initiate Pregabalin CR capsule therapy after an evening meal.

Pregabalin tablet total daily dose (dosed 2 or 3 times daily): Pregabalin CR capsule capsule dose (dosed once a day)
  • 75 mg/daily: 82.5 mg/day
  • 150 mg/daily: 165 mg/day
  • 225 mg/daily: 247.5 mg/day
  • 300 mg/daily: 330 mg/day
  • 450 mg/daily: 495 mg/day
  • 600 mg/daily: 660 mg/day

Interaction

Pregabalin is unlikely to be involved in significant pharmacokinetic drug interactions.

Contraindications

Pregabalin is contraindicated in patients with known hypersensitivity to Pregabalin or any of its components.

Side Effects

Most common side effects in adults are dizziness, somnolence, dry mouth, edema, blurred vision, weight gain and thinking abnormal (primarily difficulty with concentration/attention). Most common side effects in pediatric patients for the treatment of partial onset seizures are increased weight and increased appetite.

Pregnancy & Lactation

There are no adequate and well-controlled studies with pregabalin in pregnant women. Pregnant women should be advised of the potential risk to a fetus. Small amounts of pregabalin have been detected in the milk of lactating women. Because of the potential risk of tumorigenicity, breastfeeding is not recommended during treatment with pregabalin.

Precautions & Warnings

Angioedema (e.g., swelling of the throat, head and neck) can occur and may be associated with life threatening respiratory compromise requiring emergency treatment. Pregabalin should be discontinued immediately in these cases. Pregabalin should also be discontinued immediately if hypersensitivity reactions (e.g., hives, dyspnea and wheezing) occur. Antiepileptic drugs, including pregabalin, increase the risk of suicidal thoughts or behavior. Respiratory depression may occur with pregabalin when used with concomitant CNS depressants or in the setting of underlying respiratory impairment. Patients need to be monitored and dosage adjusted as appropriate. Pregabalin may cause dizziness and somnolence and impair patients ability to drive or operate machinery. Increased seizure frequency or other adverse reactions may occur if pregabalin is rapidly discontinued. Pregabalin should be withdrawn gradually over a minimum of 1 week. Pregabalin may cause peripheral edema. Caution should be exercised when coadministering pregabalin and thiazolidinedione antidiabetic agents.

Overdose Effects

In case of overdose with pregabalin, sign and symptoms are reduced consciousness, depression/anxiety, confusional state, agitation and restlessness. Seizures and heart block have also been reported. There is no specific antidote. If indicated, elimination of unabsorbed drug may be attempted by emesis or gastric lavage; usual precautions should be observed to maintain the airway. General supportive care of the patient is indicated including monitoring of vital signs and observation of the clinical status of the patient.

Storage Conditions

Keep in a cool & dry place (below 30°C), protected from light & moisture. Keep out of the reach of children.

Alternative brands of Pregabalin

Other brands with the same generic name, cheapest first.

Gabarol Capsule

25 mg

Pregabalin

Advanced Chemical Industries PLC

৳ 11.00 per unit

Algaba Capsule

50 mg

Pregabalin

Al-Madina Pharmaceuticals Ltd.

৳ 12.00 per unit

See all 105 brands

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.